BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 2899835)

  • 1. Nizatidine (AXID).
    Med Lett Drugs Ther; 1988 Aug; 30(772):77-8. PubMed ID: 2899835
    [No Abstract]   [Full Text] [Related]  

  • 2. A comparison of nizatidine with the three other histamine receptor antagonists for duodenal ulcer therapy.
    Lima M; Holdcroft C
    Nurse Pract; 1989 Feb; 14(2):41-2. PubMed ID: 2564655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nizatidine and ranitidine in the short-term treatment of duodenal ulcer: a cooperative double-blind study of once-daily bedtime administration.
    Pace F; Colombo E; Ferrara A; Prada A; Rocca F; Bianchi Porro G
    Am J Gastroenterol; 1988 Jun; 83(6):643-5. PubMed ID: 2897784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nizatidine: a new histamine receptor blocker in the treatment of active duodenal ulcers.
    Levendoglu H; Mehta B; Wait C; Reddy G; Hatcher C
    Am J Gastroenterol; 1986 Dec; 81(12):1167-70. PubMed ID: 2878607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Famotidine (Pepcid).
    Med Lett Drugs Ther; 1987 Feb; 29(733):17-8. PubMed ID: 2880282
    [No Abstract]   [Full Text] [Related]  

  • 6. [Nizatidine].
    Romero M; Franzosi MG
    Medicina (Firenze); 1989; 9(1):93-6. PubMed ID: 2567957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fourth histamine antagonist, nizatidine, reaches U.S. market.
    Clin Pharm; 1988 Aug; 7(8):560. PubMed ID: 2901936
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical review of histamine2 receptor antagonists.
    Lipsy RJ; Fennerty B; Fagan TC
    Arch Intern Med; 1990 Apr; 150(4):745-51. PubMed ID: 1970232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nizatidine. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in peptic ulcer disease.
    Price AH; Brogden RN
    Drugs; 1988 Nov; 36(5):521-39. PubMed ID: 2905640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparison of famotidine and ranitidine in duodenal ulcer].
    Rohner HG; Gugler R; Kimmig JM; Schönekäs H
    Dtsch Med Wochenschr; 1987 Feb; 112(9):367-8. PubMed ID: 2880704
    [No Abstract]   [Full Text] [Related]  

  • 11. Healing and recurrence of active duodenal ulcer with nizatidine.
    Cloud ML; Offen WW; Matsumoto C; Chernish SM
    Clin Pharmacol Ther; 1989 Sep; 46(3):310-6. PubMed ID: 2570656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histamine H2-receptor antagonists.
    Pounder R
    Baillieres Clin Gastroenterol; 1988 Jul; 2(3):593-608. PubMed ID: 2901868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of duodenal ulceration in the United States.
    Dyck WP; Cloud ML; Offen WW; Matsumoto C; Chernish SM
    Scand J Gastroenterol Suppl; 1987; 136():47-55. PubMed ID: 2892255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nizatidine versus cimetidine in the treatment of duodenal ulcers.
    Yap CK; Chong YY; Chia SC; Fock KM
    Ann Acad Med Singap; 1991 Mar; 20(2):241-3. PubMed ID: 1679316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nizatidine as maintenance therapy of duodenal ulcer disease in remission.
    Cerulli MA; Cloud ML; Offen WW; Chernish SM; Matsumoto C
    Scand J Gastroenterol Suppl; 1987; 136():79-83. PubMed ID: 2892259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of nizatidine in clinical trials conducted in the USA and Europe.
    Cloud ML
    Scand J Gastroenterol Suppl; 1987; 136():29-36. PubMed ID: 2892253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Famotidine. Pharmacologic and clinical profile of the new histamine H2 receptor antagonist].
    Müller P; Dammann HG; Simon B
    Fortschr Med; 1986 Apr; 104(15):319-22. PubMed ID: 2872147
    [No Abstract]   [Full Text] [Related]  

  • 18. New histamine H2-receptor antagonists.
    Domschke S; Domschke W
    Hepatogastroenterology; 1980 Jun; 27(3):163-8. PubMed ID: 6109690
    [No Abstract]   [Full Text] [Related]  

  • 19. Nizatidine in peptic ulcer disease. Proceeedings of the First International Symposium on Nizatidine. Vienna, 11 and 12 October 1986.
    Scand J Gastroenterol Suppl; 1987; 136():1-88. PubMed ID: 2892250
    [No Abstract]   [Full Text] [Related]  

  • 20. A comparison of two doses of nizatidine versus placebo in the treatment of reflux oesophagitis.
    Quik RF; Cooper MJ; Gleeson M; Hentschel E; Schuetze K; Kingston RD; Mitchell M
    Aliment Pharmacol Ther; 1990 Apr; 4(2):201-11. PubMed ID: 1983322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.